Trade TLSI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
TriSalus Life Sciences, Inc. (TLSI) is trading at US$4.78, down 3.06% today as of Aug 28, 13:04 EDT. The company has a market capitalisation of US$324.5M. Over the past 52 weeks, TLSI has traded between US$2.20 and US$7.95. On Syfe you can trade TLSI with $0 commission and add it to your watchlist.
| Previous close | US$4.93 |
|---|---|
| Market cap | US$324.5M |
| 52-week range | US$2.20 – US$7.95 |
| Volume | 74.33K |
| Exchange | US |
Add to Watchlist
Set Price Alert
TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.
Year: 2023
Top Midday Decliners
May 13, 6:03 PM · MT Newswires
TriSalus Life Sciences Swings to Q1 Earnings, Revenue Declines
May 12, 8:48 PM · MT Newswires
TriSalus Life Sciences, Inc. (TLSI) stock is trading at US$4.78, -3.06% from the previous close of US$4.93.
The market cap for TriSalus Life Sciences, Inc. (TLSI) stock is approximately US$324.5M.
The 52-week high for TriSalus Life Sciences, Inc. (TLSI) stock is US$7.95.
The 52-week low for TriSalus Life Sciences, Inc. (TLSI) stock is US$2.20.
TriSalus Life Sciences, Inc. (TLSI) does not currently pay a dividend.
Stay on top of TLSI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
